ASP基因rs2250656位点多态性与新疆汉族及少数民族脂质代谢及冠心病严重程度的相关性研究

李雯, 李天贵, 沙吉旦·阿不都热衣木, 等. ASP基因rs2250656位点多态性与新疆汉族及少数民族脂质代谢及冠心病严重程度的相关性研究[J]. 临床心血管病杂志, 2020, 36(10): 895-899. doi: 10.13201/j.issn.1001-1439.2020.10.005
引用本文: 李雯, 李天贵, 沙吉旦·阿不都热衣木, 等. ASP基因rs2250656位点多态性与新疆汉族及少数民族脂质代谢及冠心病严重程度的相关性研究[J]. 临床心血管病杂志, 2020, 36(10): 895-899. doi: 10.13201/j.issn.1001-1439.2020.10.005
LI Wen, LI Tiangui, Shajidan·ABUDUREYIMU, et al. Association of ASP gene rs2250656 locus polymorphism with lipid metabolism and severity of coronary heart disease in Xinjiang Han and ethnic minorities[J]. J Clin Cardiol, 2020, 36(10): 895-899. doi: 10.13201/j.issn.1001-1439.2020.10.005
Citation: LI Wen, LI Tiangui, Shajidan·ABUDUREYIMU, et al. Association of ASP gene rs2250656 locus polymorphism with lipid metabolism and severity of coronary heart disease in Xinjiang Han and ethnic minorities[J]. J Clin Cardiol, 2020, 36(10): 895-899. doi: 10.13201/j.issn.1001-1439.2020.10.005

ASP基因rs2250656位点多态性与新疆汉族及少数民族脂质代谢及冠心病严重程度的相关性研究

  • 基金项目:

    国家自然科学基金项目(No:81660040)

    2020年新疆维吾尔自治区研究生科研创新项目(No:XJ2020G205)

详细信息
    通讯作者: 高颖,E-mail:sunflowergaoying@163.com
  • 中图分类号: R541.4

Association of ASP gene rs2250656 locus polymorphism with lipid metabolism and severity of coronary heart disease in Xinjiang Han and ethnic minorities

More Information
  • 目的:探讨ASP基因rs2250656位点多态性与新疆汉族及少数民族脂质代谢及冠心病严重程度的相关性。方法:纳入新疆地区冠心病患者818例,其中汉族组489例,少数民族组329例。采用SNPscanTM高通量基因分型技术检测所纳入患者基因多态性,并检测血脂水平及冠状动脉(冠脉)病变程度。结果:ASP基因rs2250656位点TT基因型汉族组(61.8%)明显高于少数民族组(52.9%),TC基因型少数民族组(32.9%)明显高于汉族组(41.3%),分布差异有统计学意义(P<0.05),两组等位基因T与C频率分布差异有统计学意义(P<0.05)。少数民族组基因型亚组间的甘油三酯水平差异有统计学意义(P<0.05),其中CC基因型甘油三酯水平明显高于TT基因型及TC基因型;少数民族组基因型亚组间的冠脉病变程度差异有统计学意义(P<0.05),其中CC基因型病变严重程度高于TT基因型及TC基因型。结论:ASP基因rs2250656位点C等位基因与少数民族冠心病患者甘油三酯增高有一定相关性,CC基因型可能是少数民族冠心病的危险因素之一,而其与汉族冠心病的发病可能无一定的关联性。
  • 加载中
  • [1]

    胡盛寿,高润霖,刘力生,等.《中国心血管病报告2018》概要[J].中国循环杂志,2019,34(3):209-220.

    [2]

    Pencina MJ,Navar AM,Wojdyla D,et al.Quantifying importance of major risk factors for coronary heart disease[J].Circulation,2019,139(13):1603-1611.

    [3]

    Tang Y,Ke ZP,Peng YG,et al.Co-expression analysis reveals key gene modules and pathway of human coronary heart disease[J].J Cell Biochem,2018,119(2):2102-2109.

    [4]

    Castellano-Castillo D,Moreno-Indias I,Fernandez-Garcia JC,et al.Complement factor C3 methylation and mRNA expression is associated to BMI and insulin resistance in obesity[J].Genes(Basel),2018,9(8).

    [5]

    Maslowska M,Wang HW,Cianflone K.Novel roles for acylation stimulating protein/C3adesArg:a review of recent in vitro and in vivo evidence[J].Vitam Horm,2005,70:309-332.

    [6]

    Al-Kuraishy HM,Al-Gareeb AI.Acylation-stimulating protein is a surrogate biomarker for acute myocardial infarction:Role of statins[J].J Lab Physicians,2017,9(3):163-169.

    [7]

    Maneerat Y,Prasongsukarn K,Benjathummarak S,et al.PPBP and DEFA1/DEFA3 genes in hyperlipidaemia as feasible synergistic inflammatory biomarkers for coronary heart disease[J].Lipids Health Dis,2017,16(1):80.

    [8]

    Karaçağlar E,Akgün AN,Müderrisoğlu IH,et al.Coronary Angiography for Follow-up of Heart Transplant Recipients:Usefulness of the Gensini Score[J].Exp Clin Transplant,2020,18(Suppl 1):99-104.

    [9]

    Wu J,Jiao ZY,Li RZ,et al.Cholinergic activation suppresses palmitate-induced macrophage activation and improves acylation stimulating protein resistance in co-cultured adipocytes[J].Exp Biol Med(Maywood),2017,242(9):961-973.

    [10]

    Zheng YY,Xie X,Ma YT,et al.Association of C5 L2 genetic polymorphisms with coronary artery disease in a Han population in Xinjiang,China[J].Oncotarget,2017,8(5):8590-8596.

    [11]

    Jiao ZY,Wu J,Liu C,et al.Nicotinic α7 receptor inhibits the acylation stimulating protein-induced production of monocyte chemoattractant protein-1 and keratinocyte-derived chemokine in adipocytes by modulating the p38 kinase and nuclear factor-κB signaling pathways[J].Mol Med Rep,2016,14(4):2959-2966.

    [12]

    Mishra S,Gupta V,Mishra S,et al.Association of acylation stimulating protein and adiponectin with metabolic risk marker in North Indian obese women[J].Diabetes Metab Syndr,2019,13(5):2987-2990.

    [13]

    Barbu A,Hamad OA,Lind L,et al.The role of complement factor C3 in lipid metabolism[J].Mol Immunol,2015,67(1):101-107.

    [14]

    国家卫生计生委疾病预防控制局.中国居民营养与慢性病状况报告(2015年)[M].北京:人民卫生出版社,2015.

    [15]

    Jiang H,Liu X,Wang D,et al.Association of acylation-stimulating protein and receptor gene polymorphisms with coronary heart disease in Han and Hui populations[J].Int J Clin Exp Med,2015,8(10):18779-18785.

    [16]

    Chen Y,Ma YT,Yang SJ,et al.Relationship between the acylation-stimulating protein gene and coronary heart disease in the Xinjiang Uygur and Han populations of China[J].Genet Mol Res,2014,13(2):2638-2644.

    [17]

    杨思进,马依彤,谢翔,等.新疆维、汉民族促酰化蛋白基因301T>C多态性分布特征及其与血脂的关系[J].中华心血管病杂志,2012,40(11):929-932.

    [18]

    Phillips CM,Goumidi L,Bertrais S,et al.Complement component 3 polymorphisms interact with polyunsaturated fatty acids to modulate risk of metabolic syndrome[J].Am J Clin Nutr,2009,90(6):1665-1673.

  • 加载中
计量
  • 文章访问数:  150
  • PDF下载数:  79
  • 施引文献:  0
出版历程
收稿日期:  2020-05-25
修回日期:  2020-07-17

目录